Information Library

Results for: Oncology - High-quality studies

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Forms New Biomarker Research and Development Company

    Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    White Paper — June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • Quintiles and Population Genetics Technologies Partner

    Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

  • Dr. Frank Massam

    Hear from the Experts — May 13, 2011
    Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

  • CardioCheck

    White Paper — May 10, 2011
    Quintiles' CardioCheck program is designed to provide rapid insight into potential cardiotoxic influences of pharmaceutical compounds.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Oncology Expertise - Scientific Collaborator for Global Solutions

    Brochure — January 28, 2011
    Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you.

  • Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India

    Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.

  • Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries

    Presentation — October 1, 2010
    Download Christopher Ung of Quintiles recent presentation, Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries from the Clinical Development of Cancer Drugs in China

  • Personalized Anti-Cancer Therapy Development in China

    Presentation — October 1, 2010
    Download the slides from Michael Shi, M.D. of Novartis recent presentation, Personalized Anti-Cancer Therapy Development in China from the Clinical Development of Cancer Drugs in China

Page 1 of 2 (16 results)

Subscribe to Email Based on Your Interests

Set preferences